Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT
Clinical trial NCT06075238 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06075238
- Sponsor
- Sichuan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2024-09-30
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.